Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. LifeTech Scientific's retained earnings for the quarter that ended in Dec. 2025 was HK$2,234 Mil.
LifeTech Scientific's quarterly retained earnings
increased
from Dec. 2024 (HK$2,001 Mil) to Jun. 2025 (HK$2,109 Mil) and
increased
from Jun. 2025 (HK$2,109 Mil) to Dec. 2025 (HK$2,234 Mil).
LifeTech Scientific's annual retained earnings
increased
from Dec. 2023 (HK$1,807 Mil) to Dec. 2024 (HK$2,001 Mil) and
increased
from Dec. 2024 (HK$2,001 Mil) to Dec. 2025 (HK$2,234 Mil).
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
LifeTech Scientific Retained Earnings Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Retained Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
What does a Retained Earnings of HK$2,234 Mil mean?
LifeTech Scientific (HKSE:01302) has a Retained Earnings of HK$2,234 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on LifeTech Scientific and its competitors.
Is LifeTech Scientific's Retained Earnings too high?
LifeTech Scientific's current Retained Earnings is HK$2,234 Mil. Overall, LifeTech Scientific has a GF Score™ of 95/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Retained Earnings compare to ABT and SYK?
LifeTech Scientific's Retained Earnings of HK$2,234 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on LifeTech Scientific and its competitors. LifeTech Scientific's current Retained Earnings is HK$2,234 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
Based on GuruFocus' analysis, LifeTech Scientific (HKSE:01302) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.17, compared to a current price of HK$1.35 — trading 38% below its estimated fair value. The current Retained Earnings is HK$2,234 Mil. LifeTech Scientific's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For LifeTech Scientific (HKSE:01302), the current Retained Earnings is HK$2,234 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (HKSE:01302) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of HK$1.35 is trading 38% below its estimated GF Value™ of HK$2.17.
GuruFocus considers LifeTech Scientific to be Possible Value Trap.
Key valuation signals for HKSE:01302:
Retained Earnings: HK$2,234 Mil
GF Value™: HK$2.17 vs. price of HK$1.35 (38% below fair value)
No single metric tells the full story. See the HKSE:01302 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
95GF Score
Get the complete analysis for HKSE:01302
Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01302 has been successfully added to your 
